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Elevated levels of tumour necrosis factor 
(TNF)-a, interleukin (IL)-1b and IL-10 in 
hidradenitis suppurativa skin: a rationale  
for targeting TNF-a and IL-1b
van der Zee et al. determined the cytokine profile in skin 
from patients with hidradenitis suppurativa (HS) com-
pared with healthy and psoriasis skin. The proinflammatory 
cytokines interleukin (IL)-1b and TNF-a as well as the anti-
inflammatory cytokine IL-10 were elevated in lesional and 
peri-lesional HS skin. This demonstrates that HS inflam-
mation extends beyond the visually inflamed border, an 
explanation for high post-operative recurrence rates. The 
levels of especially IL-1b, IL-10 but also TNF-a in HS were 
higher than those in psoriasis. Results provide a rationale 
for targeting these cytokines with specific biologics in 
patients with HS. Br J Dermatol 2011; 164: 1292–98.
Severe lower limb cellulitis is best diagnosed 
by dermatologists and managed with shared 
care between primary and secondary care
Levell et al. designed a new model of care for lower limb 
cellulitis. Diagnosis was undertaken by dermatologists 
and the cellulitis was treated with oral or once daily intra-
venous antibiotics, when possible, at home. Twenty-eight 
per cent of patients with confirmed cellulitis had another 
skin disease diagnosed that could be treated to reduce 
recurrence risk. Ninety-six per cent of confirmed cases were 
managed without hospital admission. Of people referred, 
33% had alternative diagnoses made by dermatologists, 
avoiding the need for unnecessary cellulitis treatment, 
highlighting education needs. This model of care improved 
patient care and created substantial financial savings. Br J 
Dermatol 2011; 164: 1326–28.
Cutaneous lupus erythematosus and 
the association with systemic lupus 
erythematosus: a population-based  
cohort of 1088 patients in Sweden
In this study Grönhagen et al. used the Swedish National 
Patient Registry to estimate the incidence of cutaneous 
lupus erythematosus (CLE), and the probability of receiving 
an SLE diagnosis. The incidence of CLE was 4.0⁄100000; 
the female⁄male ratio was 3:1. Mean age at disease onset 
was 54 years. A quarter of the patients were already diag-
nosed with SLE. During the first 3 years post-CLE diagnosis, 
the probability of also being diagnosed with SLE was 18%. 
The need for monitoring and follow-up are called for in this 
patient group due to the risk of SLE. Br J Dermatol 2011; 
164: 1335–41.
Immediate pigment darkening and  
persistent pigment darkening as means of 
measuring the UVA protection factor in vivo: 
A comparative study
The authors conclude that the immediate pigment darken-
ing (IPD) method can be used as an appropriate endpoint 
in the determination of UVA protection factor (UVAPF). 
IPD is advantageous over persistent pigment darkening 
(PPD) in that it can be timesaving, particularly when testing 
sunscreen products with higher UVAPF, sparing subjects 
from unwanted UVA exposure and preventing errors that 
may arise from photo-degradation of active ingredients 
in sunscreens when the irradiation time is prolonged. For 
effective protection against UVA, precise application of the 
recommended 2.0 mg cm–2 of sunscreen is reported as cru-
cial. Br J Dermatol 2011; 164: 1356–61.
Impaired IFN-a secretion by plasmacytoid 
dendritic cells induced by TLR9 activation  
in chronic idiopathic urticaria
Sato et al. identified a disturbed innate immune response in 
chronic idiopathic urticaria (CIU), related to Toll-like recep-
tor 9 (TLR9) mediated activation and indicating a functional 
impairment of plasmacytoid dendritic cells (pDC). The find-
ings showed a mild IFN-a secretion by pDC upon stimula-
tion by CpG A, associated with a down regulation of TLR9 
mRNA expression. In addition, a normal pDC percentage 
in the peripheral blood cells and rare pDC recruitment at 
the skin lesion in CIU was found. The alteration of innate 
immune response sensing through TLR9 by pDC supports 
the concept of immunological dysregulation in CIU. A 
search for a TLR ligand response of dendritic cells linking 
innate to adaptive immunity could be useful for therapeutic 
purposes. Br J Dermatol 2011; 164: 1271–79.
